Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with oxaliplatin for peritoneal carcinomatosis arising from colorectal cancer.

@article{Gervais2013CytoreductiveSP,
  title={Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with oxaliplatin for peritoneal carcinomatosis arising from colorectal cancer.},
  author={Mai-Kim Gervais and Pierre Dub{\'e} and Yarrow J. McConnell and Pierre Drolet and Andrew R. Mitchell and Lucas Sid{\'e}ris},
  journal={Journal of surgical oncology},
  year={2013},
  volume={108 7},
  pages={438-43}
}
BACKGROUND Peritoneal carcinomatosis (PC) from colorectal cancer is associated with a poor prognosis. Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) have improved survival compared to systemic chemotherapy. We evaluate the results of this treatment in our institution. METHODS Treatment consisted of complete CRS followed by HIPEC with oxaliplatin (460 mg/m(2) ) in 2 L/m(2) of D5W at 42°C during 30 min. RESULTS From 2004 to 2011, 40 patients with PC from… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 10 extracted citations

Similar Papers

Loading similar papers…